Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential.
about
Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma.Global acetylation and methylation changes predict papillary urothelial neoplasia of low malignant potential recurrence: a quantitative analysis.Fractal characteristics of May-Grünwald-Giemsa stained chromatin are independent prognostic factors for survival in multiple myeloma.EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients--a case control study.Quantitative characterization of preneoplastic progression using single-cell computed tomography and three-dimensional karyometryNuclear morphometry identifies a distinct aggressive cellular phenotype in cutaneous squamous cell carcinoma.Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growthPotential use of quantitative tissue phenotype to predict malignant risk for oral premalignant lesionsKnowledge discovery processing and data mining in karyometry.Automatic segmentation of cell nuclei in bladder and skin tissue for karyometric analysis.
P2860
Q33595376-9A1BD6B2-E895-4D3E-A594-A0C02E2508CFQ33723478-BEB14CF9-F8CB-427B-A87C-B74C26A3F500Q33941055-919F7BFB-393D-4ABA-AA9B-08D21DE2738EQ33948741-27DFB5A5-A0DD-4854-BAF8-CB2F5D8288ACQ34747959-98DBC0EB-7E6E-4E49-A83D-31B0922F4A02Q35235816-43345AAD-5219-4811-A87C-5975963FB993Q35555875-FC4A952C-D820-4C6A-8D8C-C5E65D37D629Q37218761-A274C3D6-9B4B-41AD-B4E5-58EF3D3BEB31Q51808571-E61DA683-2AEE-450A-92E9-72902FA5C37AQ51835466-3F8070FB-63F9-4201-B071-DDE645FDBC93
P2860
Chromatin phenotype karyometry can predict recurrence in papillary urothelial neoplasms of low malignant potential.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Chromatin phenotype karyometry ...... ms of low malignant potential.
@en
Chromatin phenotype karyometry ...... ms of low malignant potential.
@nl
type
label
Chromatin phenotype karyometry ...... ms of low malignant potential.
@en
Chromatin phenotype karyometry ...... ms of low malignant potential.
@nl
prefLabel
Chromatin phenotype karyometry ...... ms of low malignant potential.
@en
Chromatin phenotype karyometry ...... ms of low malignant potential.
@nl
P2093
P356
P1433
P1476
Chromatin phenotype karyometry ...... sms of low malignant potential
@en
P2093
Antonio Lopez-Beltran
David Alberts
Hubert G Bartels
James Ranger-Moore
Janine Einspahr
Marina Scarpelli
Peter H Bartels
Peter W Hamilton
Roberta Mazzucchelli
Rodolfo Montironi
P356
10.1155/2007/356464
P577
2007-01-01T00:00:00Z